Abstract
Knowledge concerning IgA nephropathy has expanded greatly in the last 10 years, and its importance as the major form of glomerulonephritis and major contributor to the endstage renal disease is becoming apparent in children and adults. IgA nephropathy is a slowly progressive glomerular disease. Once renal function impairment develops, eventual progression to uremia is inevitable, and so a prophylactic approach to the progression of IgA nephropathy, based on an arbitrary period of therapy early in the course of disease, warrants serious consideration and investigation. A program of urinalysis screening in schools and an appropriate renal biopsy policy make an early diagnosis of IgA nephropathy possible. The development of successful therapy during childhood will offer a great potential for reducing the high morbidity and mortality associated with this disease in adults.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
